A Stage 1/2 test revealed mainly moderate to modest and short-term adverse effects with ALK’s peanut allergic reaction vaccination prospect.
发布者:BY MARKETWIRE,转转请注明出处:https://robotalks.cn/alk-enters-phase-2-after-positive-results-for-peanut-allergy-vaccine-2/